UPNA partners & Genbioma have shown latest results on “Effectiveness of co-administration of metformin and pA1c ? in Type-2 Diabetes” at 14th SEMiPyP.

UPNA partners & Genbioma have shown latest results on “Effectiveness of co-administration of metformin and pA1c ? in Type-2 Diabetes” at 14th SEMiPyP.

Genbioma Genbioma

Genbioma

The Microbiome Science for Metabolic Health. Postbiotics for Human Health

发布日期: 2023年3月9日
+ 关注

Universidad Pública de Navarra partners (@Miriam Ara?a, Miguel Angel Barajas Velez ) and Genbioma ( Josune Ayo ) have presented?today, March 9th , during the Spanish Society on Microbiota, Probiotics and Prebiotics?Sociedad Espa?ola de Microbiota, Probióticos y Prebióticos?(SEMiPyP) 2023, the latest results on “Effectiveness of co-administration of metformin and?Pediococcus acidilactici?pA1c ? in Type-2 Diabetes”.

Venue: Baluarte, Pamplona.?March 8th-10th

Poster presentation. Session 2. Clinical Use. 11:15-11:45 AM (Terrasse 1, 1st floor):

P16:?“Efectividad de la coadministración de metformina y?Pediococcus acidilactici?pA1c ? en diabetes mellitus tipo 2)?@Miriam Ara?a et al.

This exciting outcome is due to the fruitful research collaboration between Universidad Pública de Navarra and Genbioma (UPNA spin-off).

Looking forward to more promising synergies!

Miguel Angel Barajas Velez and @Miriam Ara?a, are experts, among others, on #diabetes?,?#gutmicrobiota , #preclinicalresearch and #biomarkers.?

Thank you SEMiPyP for such opportunity!

See you next year!

要查看或添加评论，请登录

Genbioma的更多文章

社区洞察

其他会员也浏览了